Latest filing published 30 Dec 2020 for Aurinia Pharmaceuticals Inc., €20k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Massimiliano Colao: trading record in brief
All filings by Massimiliano Colao on record concern Aurinia Pharmaceuticals Inc. Between 2 March 2020 and 29 December 2020, the trades on record add up to 5 filings.
Purchases make up the whole of the open-market record (4 purchases, €72k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €19k and half below.
Most recently, on 30 December 2020, the filings show an open-market purchase worth €20k in Aurinia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 8 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Massimiliano Colao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,200 shares@ CA$13.92Common SharesTSXSEDI:3651683Canonical exit: 29 Mar 2021 (T+90)
- 2,000 shares@ CA$14.29Common SharesTSXSEDI:3651681Canonical exit: 28 Mar 2021 (T+90)
- 800 shares@ CA$13.52Common SharesTSXSEDI:3651680Canonical exit: 22 Mar 2021 (T+90)
- 3,200 shares@ CA$13.51Common SharesTSXSEDI:3651679Canonical exit: 22 Mar 2021 (T+90)
- Common SharesTSXSEDI:3519980
5 of 5 declarations
